Department of Neurosurgery, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem, Israel, 01120.
Department of Neurosurgery, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem, Israel, 01120.
Spine J. 2018 Jul;18(7):1211-1221. doi: 10.1016/j.spinee.2017.11.020. Epub 2017 Dec 28.
Metastatic epidural spinal cord compression (MESCC) is a disabling consequence of disease progression. Surgery can restore or preserve physical function, improving access to treatments that increase duration of survival; however, advanced patient age may deter oncologists and surgeons from considering surgical management.
Evaluate the duration of ambulation and survival in elderly patients following surgical decompression of MESCC.
STUDY DESIGN/SETTING: Retrospective file review of a prospective database, under institutional review board (IRB) waiver of informed consent, of consecutive patients treated in an academic tertiary care medical center from August 2008 to March 2015.
Patients ≥65 years presenting neurological and/or radiological signs of cord compression because of metastatic disease, who underwent surgical decompression.
Duration of ambulation and survival.
Patients underwent urgent multidisciplinary evaluation and surgery. Ambulation and survival were compared with age, pre-, and postoperative neurological (American Spinal Injury Association [ASIA] Impairment Scale [AIS]) and performance status (Karnofsky Performance Status [KPS]), and Tokuhashi Score using Kruskal-Wallis and Wilcoxon signed rank tests, Pearson correlation coefficient, Cox regression model, log-rank analysis, and Kaplan-Meier analysis.
Forty patients were included (21 male, 54%; mean age 74 years, range 65-87). Surgery was performed a mean 3.8 days after onset of motor symptoms. Mean duration of ambulation and survival were 474 (range 0-1662) and 525 days (range 11-1662), respectively; 53% of patients (21 of 40) survived and 43% (17 of 40) retained ambulation for ≥1 year. There was no significant relationship between survival and ambulation for patients aged 65-69, 70-79, or 80-89 years, although Kaplan-Meier analysis suggested stratification. There was a significant relationship between duration of ambulation and pre- and postoperative AIS (p=.0342, p=.0358, respectively) and postoperative KPS (p=.0221). Tokuhashi score was not significantly related to duration of survival or ambulation, and greatly underestimated life expectancy in 22 of 37 (59%) patients with scores 0-11.
Decompressive surgery led to marked improvement in neurological function and performance status. More than 50% of patients survived for >1 year, some for 3 years or more after surgery.
转移性硬膜外脊髓压迫症(MESCC)是疾病进展导致的一种致残后果。手术可以恢复或维持身体功能,增加接受延长生存时间治疗的机会;然而,由于患者年龄较大,肿瘤学家和外科医生可能会不愿意考虑手术治疗。
评估老年患者接受 MESCC 手术减压后的步行能力和生存时间。
研究设计/设置:在机构审查委员会(IRB)豁免知情同意的情况下,对 2008 年 8 月至 2015 年 3 月期间在一家学术性三级保健医疗中心接受治疗的连续患者的前瞻性数据库进行回顾性文件审查。
因转移性疾病出现神经和/或脊髓压迫影像学表现而出现神经功能障碍和/或放射学表现的年龄≥65 岁的患者,接受手术减压。
步行能力和生存时间。
患者接受紧急多学科评估和手术。使用 Kruskal-Wallis 和 Wilcoxon 符号秩检验、Pearson 相关系数、Cox 回归模型、对数秩分析和 Kaplan-Meier 分析,比较年龄、术前和术后美国脊柱损伤协会(ASIA)损伤量表(AIS)和功能状态(卡诺夫斯基绩效状态[KPS])以及 Tokuhashi 评分与步行能力和生存时间的关系。
共纳入 40 例患者(21 例男性,54%;平均年龄 74 岁,范围 65-87 岁)。出现运动症状后平均 3.8 天进行手术。平均步行时间和生存时间分别为 474(0-1662)和 525 天(11-1662);53%(21 例)的患者存活,43%(17 例)的患者在≥1 年内保留步行能力。65-69 岁、70-79 岁和 80-89 岁患者的生存时间与步行能力之间无显著关系,尽管 Kaplan-Meier 分析提示存在分层。步行能力与术前和术后 AIS(p=.0342,p=.0358)和术后 KPS(p=.0221)显著相关。Tokuhashi 评分与生存时间或步行能力无显著相关性,并且在 37 例评分 0-11 的患者中,22 例(59%)严重低估了预期寿命。
减压手术显著改善了神经功能和功能状态。超过 50%的患者存活时间超过 1 年,其中一些患者在手术后 3 年或更长时间仍存活。